These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21961028)

  • 1. Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.
    Crain JM; Watters JJ
    Open Drug Discov J; 2010 Jan; 2():148-167. PubMed ID: 21961028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.
    Elmadany N; de Almeida Sassi F; Wendt S; Logiacco F; Visser J; Haage V; Hernandez DP; Mertins P; Hambardzumyan D; Wolf S; Kettenmann H; Semtner M
    J Neurosci; 2020 Apr; 40(17):3320-3331. PubMed ID: 32060170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression.
    Potucek YD; Crain JM; Watters JJ
    Neurochem Int; 2006 Jul; 49(2):204-14. PubMed ID: 16735081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial P2 Purinergic Receptor and Immunomodulatory Gene Transcripts Vary By Region, Sex, and Age in the Healthy Mouse CNS.
    Crain JM; Watters JJ
    Transcr Open Access; 2015 Dec; 3(2):. PubMed ID: 26949719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
    Das R; Chinnathambi S
    Neuroscience; 2020 Nov; 448():325-336. PubMed ID: 32941933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons.
    Rajbhandari L; Tegenge MA; Shrestha S; Ganesh Kumar N; Malik A; Mithal A; Hosmane S; Venkatesan A
    Glia; 2014 Dec; 62(12):1982-91. PubMed ID: 25042766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y6 Receptor-Mediated Microglial Phagocytosis in Radiation-Induced Brain Injury.
    Xu Y; Hu W; Liu Y; Xu P; Li Z; Wu R; Shi X; Tang Y
    Mol Neurobiol; 2016 Aug; 53(6):3552-3564. PubMed ID: 26099306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shaping Microglial Phenotypes Through Estrogen Receptors: Relevance to Sex-Specific Neuroinflammatory Responses to Brain Injury and Disease.
    Acosta-Martínez M
    J Pharmacol Exp Ther; 2020 Oct; 375(1):223-236. PubMed ID: 32513838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.
    Fang KM; Yang CS; Sun SH; Tzeng SF
    J Neurochem; 2009 Dec; 111(5):1225-37. PubMed ID: 19860838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation.
    Zhang Z; Qin P; Deng Y; Ma Z; Guo H; Guo H; Hou Y; Wang S; Zou W; Sun Y; Ma Y; Hou W
    J Neuroinflammation; 2018 Jul; 15(1):206. PubMed ID: 30001721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases.
    Anwar S; Pons V; Rivest S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial activation and its implications in the brain diseases.
    Dheen ST; Kaur C; Ling EA
    Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.
    Milior G; Morin-Brureau M; Chali F; Le Duigou C; Savary E; Huberfeld G; Rouach N; Pallud J; Capelle L; Navarro V; Mathon B; Clemenceau S; Miles R
    J Neurosci; 2020 Feb; 40(7):1373-1388. PubMed ID: 31896671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS.
    Illes P; Rubini P; Ulrich H; Zhao Y; Tang Y
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
    Siddiqui TA; Lively S; Schlichter LC
    J Neuroinflammation; 2016 Mar; 13(1):66. PubMed ID: 27009332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia.
    Crain JM; Nikodemova M; Watters JJ
    J Neuroinflammation; 2009 Aug; 6():24. PubMed ID: 19706184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2 receptors, microglial cytokines and chemokines, and neuropathic pain.
    Tsuda M
    J Neurosci Res; 2017 Jun; 95(6):1319-1329. PubMed ID: 27376880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.